Rocket


Overview
Financials
News + Filings

 
 

Kezar Life Sciences, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues6.57.4
            Revenue growth-12.3% 
Cost of goods sold8.79.0
Gross profit-2.3-1.6
            Gross margin-35.2%-21.9%
General and administrative2.31.6
EBIT-8.7-9.0
            EBIT margin-135.2%-121.9%
Pre-tax income-8.5-9.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-8.5-9.0
            Net margin-131.7%-121.9%
 
Diluted EPS($14.21)($26.56)
Shares outstanding (diluted)0.60.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy